Current possibilities of histopathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis. How to do it?
Authors:
Radoslav Matěj 1,2,3
Authors‘ workplace:
Ústav patologie a molekulární medicíny 3. LF UK, Fakultní Thomayerova nemocnice, Praha
1; Ústav patologie 3. LF UK, Fakultní nemocnice Královské Vinohrady, Praha
2; Ústav patologie 1. LF UK, Všeobecná fakultní nemocnice, Praha
3
Published in:
Čes.-slov. Patol., 59, 2023, No. 1, p. 10-17
Category:
Reviews Article
Overview
Histopathological pattern of progressive pulmonary fibrosis could be seen in many different fibrotic lung interstitial diseases. Exact diagnosis is crucial for precise therapy, moreover, different diseases have different prognosis. The most important disorders in this group are idiopatic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis, and their separation is crucial because of totally different treatment of the patients. The aim of this review is to sum up the most important characteristics of usual interstitial pneumonia, histopathological pattern of idiopatic pulmonary fibrosis, and fibrotic hypersensitivity pneumonitis and provide a practical work-up for precise diagnostics of these diseases in the frame of effectively cooperating multidisciplinary team.
Keywords:
histopathology – hypersensitivity pneumonitis – interstitial – idiopatic pulmonary fibrosis
Sources
1. Walsh SLF, Wells AU, Desai SR, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 2016; 4: 557-565.
2. Vašáková M, Matěj R. Idiopatická plicní fibróza - problematika multidisciplinární diagnostiky a léčby ve světle nových poznatků. Cesk Patol 2016; 52(2): 85-92.
3. Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082.
4. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092.
5. Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, et al. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2093-2101.
6. Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2022; 205: e18-e47.
7. Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020; 202: e36-e69.
8. Marinescu DC, Raghu G, Remy-Jardin M, et al. Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis. Chest. 2022; 162(3): 614-629.
9. Registr EMPIRE: Úvod (registry.cz); vyhledáno 20.9. 2022
10. Hambly N, Farooqi MM, Dvorkin-Gheva A, et al. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. Eur Respir J in press 2022
11. Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011; 364: 1503-1512.
12. Ley B, Newton CA, Arnould I, et al. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. Lancet Respir Med 2017; 5: 639-647
13. Barnes H, Lu J, Glaspole I, et al. Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: a scoping review. Respir Med 2021; 184: 106444.
14. De Giacomi F, White D, Decker PA, et al. Derivation and validation of a prediction model for histopathologic fibrotic hypersensitivity pneumonitis. Respir Med 2021; 187: 106598.
15. Silva CI, Muller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288-297
16. Chung JH, Cox CW, Montner SM, et al. CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis. AJR Am J Roentgenol 2018; 210: 307-313.
17. Raghu G, Flaherty KR, Lederer DJ, et al. Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study. Lancet Respir Med 2019; 7: 487-496.
18. Richeldi L, Scholand MB, Lynch DA, et al. Utility of a molecular classifier as a complement to high-resolution computed tomography to identify usual interstitial pneumonia. Am J Respir Crit Care Med 2021; 203: 211-220.
19. Wright JL, Churg A, Hague CJ, et al. Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis. Mod Pathol 2020; 33: 616-625.
20. Churg A, Bilawich A, Wright JL. Pathology of chronic hypersensitivity pneumonitis: what is it? What are the diagnostic criteria? Why do we care? Arch Pathol Lab Med 2018; 142: 109-119.
21. Leslie KO, Wick MR. Practical pulmonary pathology. A diagnostic approach (3rd ed). Philadelphia: Elsevier; 2018.
22. Churg A. Hypersensitivity pneumonitis: new concepts and classifications. Mod Pathol 2022;35:15-27.
23. Matěj R, Nová M, Hornychová H. Histopatologické principy vyšetření intersticiálních plicních procesů. Cesk Patol 2016; 52(2): 76-84.
24. Nová M, Hornychová H, Matěj R. Intersticiální plicní onemocnění asociovaná s kouřením. Cesk Patol 2016; 52(2): 100-105.
25. Hornychová H, Nová M, Matěj R. Diferenciální diagnostika granulomatózních procesů v plicích. Cesk Patol 2016; 52(2): 93-99.
Labels
Anatomical pathology Forensic medical examiner ToxicologyArticle was published in
Czecho-Slovak Pathology
2023 Issue 1
Most read in this issue
- Methylation analysis as an auxiliary tool in cytological diagnostics of infrequent anogenital lesions - a pilot study
- Malobuněčný karcinom plic – nové poznatky o biologii nádoru
- Current possibilities of histopathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis. How to do it?
- Warthin-like papillary carcinoma: Case report